Periodic Reporting for period 1 - engineereD to Clear (Investigation on the vaccination potential of IL4i1 deficient dendritic cells in Chronic lymphocytic leukemia)

The primary objective of this project is to enhance the efficacy of dendritic cell (DC)-based immunotherapy by targeting the Il4i1 metabolic immune checkpoint. Chronic Lymphocytic Leukemia (CLL) presents unique immunosuppressive challenges, making it imperative to identify and...